Fig. 1From: Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers–Danlos contiguous gene deletion syndrome CAH-XSerum tenascin-X in healthy volunteers, patients with CAH and different CAH-X patient groups. Box plots represent the median (interquartile range) of absolute serum TNX concentrations. *P < 0.05, **P < 0.001, as determined by Kruskal–Wallis test. Comparisons between other groups were not significantBack to article page